Drug Development DAOs are Here
summary
Claims a functioning pipeline for decentralized drug funding: molecule protocol mints ipnfts that pair legal sublicenses with federated data access (Filecoin/iweave), NFTs live in the DAO treasury and can be licensed. Early metrics: 635 participants in the token auction, ~$10M in ETH/USDC treasury, 50k–$1M per grant range, ~100–120 researchers engaged, 88% yes vote on the University of Copenhagen grant completed two months ago. Outcome: live IP ownership and faster funding decisions (weeks) with ongoing deployments.
AI-written summary · about
chapters (16)
- 0:00Intro
- 0:34Longevity
- 2:01Molecule
- 2:29Valley of Death
- 3:49What is VitaDAO
- 4:48Pauls background
- 5:38VitaDAO unique features
- 7:04Launching VitaDAO
- 8:33Ecosystem overview
- 9:37Governance structure
- 13:09How does the DAO hold biotech IP
- 13:34Molecule Protocol
- 14:54Tech stack
- 15:08Biopharma NFT
- 17:29How we work
- 18:02Outlook
related talks
19mVitaDAO: Funding science with DAOs
28mDAOs and the Future of Fundraising and Collective Action
16mDoin Gud: NFTs x DAOs x Social Impact
46mDAO Tooling and Running a Decentralized Org
18mOnchain Capital Allocation: The Next Frontier
40mDAOs and Stakeholder Environmentalism
18mMetacartel: Tres Metrics para Devs
06mLightning Talk: MetaDAO